|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-3-25
|
|
pubmed:abstractText |
The benefits of inhaled corticosteroids (ICS) in reducing the mortality related to chronic obstructive pulmonary disease (COPD) are controversial.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1542-6270
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
613-22
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20233915-Administration, Inhalation,
pubmed-meshheading:20233915-Adrenal Cortex Hormones,
pubmed-meshheading:20233915-Adrenergic beta-2 Receptor Agonists,
pubmed-meshheading:20233915-Adrenergic beta-Agonists,
pubmed-meshheading:20233915-Aged,
pubmed-meshheading:20233915-Bronchodilator Agents,
pubmed-meshheading:20233915-Case-Control Studies,
pubmed-meshheading:20233915-Cohort Studies,
pubmed-meshheading:20233915-Comorbidity,
pubmed-meshheading:20233915-Databases, Factual,
pubmed-meshheading:20233915-Drug Therapy, Combination,
pubmed-meshheading:20233915-Female,
pubmed-meshheading:20233915-Humans,
pubmed-meshheading:20233915-Male,
pubmed-meshheading:20233915-Middle Aged,
pubmed-meshheading:20233915-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:20233915-Quebec,
pubmed-meshheading:20233915-Sample Size,
pubmed-meshheading:20233915-Socioeconomic Factors,
pubmed-meshheading:20233915-Time Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
|
|
pubmed:affiliation |
Université de Montréal, Québec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
